Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients
- 4 February 2010
- journal article
- research article
- Published by Elsevier BV in International Journal of Cardiology
- Vol. 138 (3), 306-307
- https://doi.org/10.1016/j.ijcard.2008.06.064
Abstract
The effects of erythropoietin administration on mitral regurgitation in patients with congestive heart failure have not yet been examined. After 2 months, erythropoietin treatment results in a significant reduction in left ventricular volumes and mitral regurgitation severity and improves hemodynamics.Keywords
This publication has 5 references indexed in Scilit:
- Ethical authorship and publishingInternational Journal of Cardiology, 2008
- Anemia Is Common in Heart Failure and Is Associated With Poor OutcomesCirculation, 2003
- Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunctionJournal of the American College of Cardiology, 2001
- The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizationsJournal of the American College of Cardiology, 2000
- Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area.Circulation, 1979